Non Alcoholic Fatty Liver, also known as hepatic steatosis, is a condition characterized by the accumulation of fat in the liver cells of individuals who do not consume excessive amounts of alcohol. This buildup of fat can lead to inflammation and damage to the liver, potentially causing serious health complications. The pathogenesis of Non Alcoholic Fatty Liver involves a complex interplay of various factors, including insulin resistance, oxidative stress, and genetic predisposition. As fat accumulates in the liver, it can disrupt normal liver function and impair the organ's ability to metabolize nutrients and detoxify the body. Diagnosis of Non Alcoholic Fatty Liver is typically made through imaging studies, such as ultrasound or MRI, and blood tests to assess liver function. Treatment options for this condition focus on lifestyle modifications, such as weight loss, dietary changes, and regular exercise, to reduce fat accumulation in the liver and improve overall liver health. In severe cases, Non Alcoholic Fatty Liver can progress to nonalcoholic steatohepatitis (NASH), a more serious form of liver disease that can lead to cirrhosis and liver failure. Therefore, early detection and management of Non Alcoholic Fatty Liver are crucial in preventing the progression of the disease and preserving liver function.